| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |